SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Price, Forecast & Analysis
FRA:56S1 • FR0013154002
56S1.DE Key Statistics, Chart & Performance
The current stock price of 56S1.DE is 180.95 EUR. In the past month the price decreased by -18.09%. In the past year, price decreased by -2.66%.
56S1.DE Technical Analysis
56S1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to 56S1.DE. 56S1.DE has an average financial health and profitability rating.
56S1.DE Financial Highlights
Over the last trailing twelve months 56S1.DE reported a non-GAAP Earnings per Share(EPS) of 4.4. The EPS increased by 25.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.98% | ||
| ROA | 3.36% | ||
| ROE | 6.55% | ||
| Debt/Equity | 0.5 |
56S1.DE Forecast & Estimates
19 analysts have analysed 56S1.DE and the average price target is 246.85 EUR. This implies a price increase of 36.42% is expected in the next year compared to the current price of 180.95.
For the next year, analysts expect an EPS growth of 21.28% and a revenue growth 7.74% for 56S1.DE
56S1.DE Ownership
56S1.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SRT3 | SARTORIUS AG-VORZUG | 39.43 | 17.469B | ||
| DIM | SARTORIUS STEDIM BIOTECH | 34.25 | 17.456B | ||
| SRT | SARTORIUS AG | 31.8 | 14.227B | ||
| QIA | QIAGEN N.V. | 18 | 8.471B | ||
| 1SXP | SCHOTT PHARMA AG& CO KGAA | 13.02 | 2.253B | ||
| EVT | EVOTEC SE | N/A | 2.04B | ||
| GXI | GERRESHEIMER AG | 6.19 | 643.826M | ||
| FF | FINE FOODS & PHARMACEUTICALS | 16.31 | 258.102M | ||
| ALECR | EUROFINS CEREP-REGR | N/A | 159M |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 56S1.DE
Company Profile
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The company is headquartered in Aubagne, Paca. The firm covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The firm operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.
Company Info
SARTORIUS STEDIM BIOTECH
Zone Industrielle les Paluds Avenue de Jouques, Bp 1051, Aubagne Cedex
Aubagne PACA FR
Employees: 9961
Phone: 33442845600
SARTORIUS STEDIM BIOTECH / 56S1.DE FAQ
What does SARTORIUS STEDIM BIOTECH do?
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The company is headquartered in Aubagne, Paca. The firm covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The firm operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.
Can you provide the latest stock price for SARTORIUS STEDIM BIOTECH?
The current stock price of 56S1.DE is 180.95 EUR. The price decreased by -0.08% in the last trading session.
Does SARTORIUS STEDIM BIOTECH pay dividends?
SARTORIUS STEDIM BIOTECH (56S1.DE) has a dividend yield of 0.39%. The yearly dividend amount is currently 0.71.
What is the ChartMill rating of SARTORIUS STEDIM BIOTECH stock?
56S1.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Would investing in SARTORIUS STEDIM BIOTECH be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 56S1.DE.
Is SARTORIUS STEDIM BIOTECH (56S1.DE) expected to grow?
The Revenue of SARTORIUS STEDIM BIOTECH (56S1.DE) is expected to grow by 7.74% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.